BSECompany Update5d ago · 25 Aug 2026, 05:19 pm
Intimation of Participation in Investor/ Analyst meet held on September 1-2, 2026 in Hong Kong
Aurobindo Pharma Ltd · 524804
✦ AI SummaryM&A
Aurobindo Pharma Ltd has announced its participation in an investor/analyst meet held on September 1-2, 2026 in Hong Kong. The meet is organized by Goldman Sachs Asia Leaders and will include one-on-one meetings and group meetings. The company's officials will be present to discuss the company's performance and future prospects. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment7/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
c7dfcc06-4e8e-4fd8-a40f-7edc4a8eb63a.pdf
View document text
August 25, 2026
To To
Listing Department, The Corporate Relations Department
NATIONAL STOCK EXCHANGE OF INDIA LIMITED BSE LIMITED
Exchange Plaza, Phiroz Jeejeebhoy Towers,
Bandra Kurla Complex, Bandra (E), 25th floor, Dalal Street,
MUMBAI -400 051 MUMBAI -400 001
Company Code No. AUROPHARMA Company Code No. 524804
Dear Sir/ Madam,
Sub: Participation in Investor / Analyst meeting
This is to inform you that the officials of the Company will be participating in the following investor / analyst
meeting.
Date Time Investor/Meeting name Type of meeting Location
September 09:00 AM to 05:00 Goldman Sachs Asia Leaders One-on-one and Hong Kong
1-2, 2026 PM (HKT) Conference Hong Kong 2026 Group meetings
The schedule of the above-mentioned meeting is subject to change and the change may occur due to exigence
on the part of the Investor / Company.
No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
Please take the above information on record.
Thanking you,
Yours faithfully,
For AUROBINDO PHARMA LIMITED
B. Adi Reddy
Company Secretary
Corp. Off.: Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad – 500 032, Telangana, India.
Tel : +91 40 6672 5000 / 6672 1200 Fax: +91 40 6707 4044.
Regd. off.: Plot No. 2, Maithrivihar, Ameerpet, Hyderabad - 500 038 Telangana., India Tel: +91 40 2373 6370/ 2374 7340 Fax: +91 40 2374 1080 / 2374 6833
Email: info@aurobindo.com Website: www.aurobindo.com